Skip to content
Merck
-
-
-
-
-
-
-
-
-
-
Merck invests heavily in expanding cancer drug portfolio with US$4 billion Daiichi Sankyo deal
USA — Merck, a pharmaceutical giant, has entered the realm of cancer drug research through a strategic partnership with Daiichi Sankyo, committing a substantial US$4…